T1 mapping cardiovascular magnetic resonance imaging to detect myocarditis—Impact of slice orientation on the diagnostic performance

European Journal of Radiology

Volumn 86, Issue , 2017, Pages 6-12

  Bohnen, Sebastian ^a   Radunski, Ulf K ^a   Lund, Gunnar K ^b   Tahir, Enver ^b   Avanesov, Maxim ^b   Stehning, Christian ^c   Schnackenburg, Bernhard ^d   Adam, Gerhard ^b   Blankenberg, Stefan ^a   Muellerleile, Kai ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

^d PHILIPS HEALTHCARE   (United States)

Author keywords

Cardiovascular magnetic resonance; Extracellular volume; Myocarditis; Slice orientation; T1 mapping

Indexed keywords

GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; GADOLINIUM;

ADULT; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; HEART SLICE; HUMAN; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; TASK PERFORMANCE; CARDIAC MUSCLE; CASE CONTROL STUDY; EVALUATION STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES;

ADULT; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS;

EID: 84994013405     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2016.10.031     Document Type: Article

References (31)

1. [1] Caforio, A.L., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S.B., Fu, M., Helio, T., Heymans, S., Jahns, R., Klingel, K., Linhart, A., Maisch, B., McKenna, W., Mogensen, J., Pinto, Y.M., Ristic, A., Schultheiss, H.P., Seggewiss, H., Tavazzi, L., Thiene, G., Yilmaz, A., Charron, P., Elliott, P.M., European Society of Cardiology Working Group on M, Pericardial D, Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 34 (2013), 2636–2648 2648–2648.
2. [2] Friedrich, M.G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L.T., White, J.A., Abdel-Aty, H., Gutberlet, M., Prasad, S., Aletras, A., Laissy, J.P., Paterson, I., Filipchuk, N.G., Kumar, A., Pauschinger, M., Liu, P., International consensus group on cardiovascular magnetic resonance in M. cardiovascular magnetic resonance in myocarditis: a JACC white paper. J. Am. Coll. Cardiol. 53 (2009), 1475–1487.
3. [3] American College of Cardiology Foundation Task Forceon Expert Consensus, D., Hundley, W.G., Bluemke, D.A., Finn, J.P., Flamm, S.D., Fogel, M.A., Friedrich, M.G., Ho, V.B., Jerosch-Herold, M., Kramer, C.M., Manning, W.J., Patel, M., Pohost, G.M., Stillman, A.E., White, R.D., Woodard, P.K., ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 55 (2010), 2614–2662.
4. [4] Ferreira, V.M., Piechnik, S.K., Dall'Armellina, E., Karamitsos, T.D., Francis, J.M., Ntusi, N., Holloway, C., Choudhury, R.P., Kardos, A., Robson, M.D., Friedrich, M.G., Neubauer, S., T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc. Imaging 6 (2013), 1048–1058.
5. [5] Thavendiranathan, P., Walls, M., Giri, S., Verhaert, D., Rajagopalan, S., Moore, S., Simonetti, O.P., Raman, S.V., Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ. Cardiovasc. Imaging 5 (2012), 102–110.
6. [6] Radunski, U.K., Lund, G.K., Stehning, C., Schnackenburg, B., Bohnen, S., Adam, G., Blankenberg, S., Muellerleile, K., CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc. Imaging 7 (2014), 667–675.
7. [7] Hinojar, R., Foote, L., Arroyo Ucar, E., Jackson, T., Jabbour, A., Yu, C.Y., McCrohon, J., Higgins, D.M., Carr-White, G., Mayr, M., Nagel, E., Puntmann, V.O., Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc. Imaging 8 (2015), 37–46.
8. [8] Friedrich, M.G., Myocardial T1: the rise of a novel biomarker continues. JACC Cardiovasc. Imaging 8 (2015), 47–49.
9. [9] Kellman, P., Hansen, M.S., T1-mapping in the heart: accuracy and precision. J. Cardiovasc. Magn. Reson., 16, 2014, 2.
10. [10] Kellman, P., Wilson, J.R., Xue, H., Bandettini, W.P., Shanbhag, S.M., Druey, K.M., Ugander, M., Arai, A.E., Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J. Cardiovasc. Magn. Reson., 14, 2012, 64.
11. [11] Kellman, P., Wilson, J.R., Xue, H., Ugander, M., Arai, A.E., Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J. Cardiovasc. Magn. Reson., 14, 2012, 63.
12. [12] Giri, S., Chung, Y.C., Merchant, A., Mihai, G., Rajagopalan, S., Raman, S.V., Simonetti, O.P., T2 quantification for improved detection of myocardial edema. J. Cardiovasc. Magn. Reson., 11, 2009, 56.
13. [13] Luetkens, J.A., Homsi, R., Sprinkart, A.M., Doerner, J., Dabir, D., Kuetting, D.L., Block, W., Andrie, R., Stehning, C., Fimmers, R., Gieseke, J., Thomas, D.K., Schild, H.H., Naehle, C.P., Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur. Heart J. Cardiovasc. Imaging 17 (2016), 154–161.
14. [14] Banypersad, S.M., Fontana, M., Maestrini, V., Sado, D.M., Captur, G., Petrie, A., Piechnik, S.K., Whelan, C.J., Herrey, A.S., Gillmore, J.D., Lachmann, H.J., Wechalekar, A.D., Hawkins, P.N., Moon, J.C., T1 mapping and survival in systemic light-chain amyloidosis. Eur. Heart J. 36 (2015), 244–251.
15. [15] Flett, A.S., Hayward, M.P., Ashworth, M.T., Hansen, M.S., Taylor, A.M., Elliott, P.M., McGregor, C., Moon, J.C., Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122 (2010), 138–144.
16. [16] Moon, J.C., Messroghli, D.R., Kellman, P., Piechnik, S.K., Robson, M.D., Ugander, M., Gatehouse, P.D., Arai, A.E., Friedrich, M.G., Neubauer, S., Schulz-Menger, J., Schelbert, E.B., Society for cardiovascular magnetic resonance I, Cardiovascular magnetic resonance working group of the european society of C, Myocardial T1 mapping and extracellular volume quantification: a society for cardiovascular magnetic resonance (SCMR) and CMR working group of the european society of cardiology consensus statement. J. Cardiovasc. Magn. Reson., 15, 2013, 92.
17. [17] Bohnen, S., Radunski, U.K., Lund, G.K., Kandolf, R., Stehning, C., Schnackenburg, B., Adam, G., Blankenberg, S., Muellerleile, K., Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure. Circ. Cardiovasc. Imaging, 8, 2015.
18. [18] Arheden, H., Saeed, M., Higgins, C.B., Gao, D.W., Bremerich, J., Wyttenbach, R., Dae, M.W., Wendland, M.F., Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211 (1999), 698–708.
19. [19] Jerosch-Herold, M., Sheridan, D.C., Kushner, J.D., Nauman, D., Burgess, D., Dutton, D., Alharethi, R., Li, D., Hershberger, R.E., Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 295 (2008), H1234–H1242.
20. [20] Schelbert, E.B., Testa, S.M., Meier, C.G., Ceyrolles, W.J., Levenson, J.E., Blair, A.J., Kellman, P., Jones, B.L., Ludwig, D.R., Schwartzman, D., Shroff, S.G., Wong, T.C., Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J. Cardiovasc. Magn. Reson., 13, 2011, 16.
21. [21] Ugander, M., Oki, A.J., Hsu, L.Y., Kellman, P., Greiser, A., Aletras, A.H., Sibley, C.T., Chen, M.Y., Bandettini, W.P., Arai, A.E., Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur. Heart J. 33 (2012), 1268–1278.
22. [22] Wong, T.C., Piehler, K., Meier, C.G., Testa, S.M., Klock, A.M., Aneizi, A.A., Shakesprere, J., Kellman, P., Shroff, S.G., Schwartzman, D.S., Mulukutla, S.R., Simon, M.A., Schelbert, E.B., Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126 (2012), 1206–1216.
23. [23] Saeed, M., Higgins, C.B., Geschwind, J.F., Wendland, M.F., T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur. Radiol. 10 (2000), 310–318.
24. [24] Wendland, M.F., Saeed, M., Lauerma, K., Derugin, N., Mintorovitch, J., Cavagna, F.M., Higgins, C.B., Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI. Magn. Reson. Med. 37 (1997), 448–456.
25. [25] Nacif, M.S., Turkbey, E.B., Gai, N., Nazarian, S., van der Geest, R.J., Noureldin, R.A., Sibley, C.T., Ugander, M., Liu, S., Arai, A.E., Lima, J.A., Bluemke, D.A., Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J. Magn. Reson. Imaging 34 (2011), 1367–1373.
26. [26] Francone, M., Chimenti, C., Galea, N., Scopelliti, F., Verardo, R., Galea, R., Carbone, I., Catalano, C., Fedele, F., Frustaci, A., CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc. Imaging 7 (2014), 254–263.
27. [27] Radunski, U.K., Lund, G.K., Saring, D., Bohnen, S., Stehning, C., Schnackenburg, B., Avanesov, M., Tahir, E., Adam, G., Blankenberg, S., Muellerleile, K., T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis. Clin. Res. Cardiol., 2016.
28. [28] Lurz, P., Luecke, C., Eitel, I., Fohrenbach, F., Frank, C., Grothoff, M., de Waha, S., Rommel, K.P., Lurz, J.A., Klingel, K., Kandolf, R., Schuler, G., Thiele, H., Gutberlet, M., Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the myoRacer-trial. J. Am. Coll. Cardiol. 67 (2016), 1800–1811.
29. [29] Rommel, K.P., von Roeder, M., Latuscynski, K., Oberueck, C., Blazek, S., Fengler, K., Besler, C., Sandri, M., Lucke, C., Gutberlet, M., Linke, A., Schuler, G., Lurz, P., Extracellular volume fraction for characterization of patients with heart failure and preserved ejection fraction. J. Am. Coll. Cardiol. 67 (2016), 1815–1825.
30. [30] Kawel, N., Nacif, M., Zavodni, A., Jones, J., Liu, S., Sibley, C.T., Bluemke, D.A., T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J. Cardiovasc. Magn. Reson., 14, 2012, 26.
31. [31] Kawel, N., Santini, F., Haas, T., Froehlich, J.M., Bremerich, J., The protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson., 14, 2012, 71.